Skip to content
TrialScanner

NCT01764854

Pharmacodynamic Study of AZD1722 in End-stage Renal Disease Patients on Hemodialysis

Phase 2CompletedARDXLeadAZNCollaborator

Registry record

Lead sponsor
Ardelyx
Conditions
End Stage Renal Disease; Chronic Kidney Disease Stage 5; ESRD
Primary completion
Oct 2013Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT01764854 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT01764854: Pharmacodynamic Study of... | TrialScanner